We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$376B
AUM Growth
+$22.5B
Cap. Flow
+$9.39B
Cap. Flow %
2.5%
Top 10 Hldgs %
15.22%
Holding
6,974
New
204
Increased
3,048
Reduced
3,002
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 9.45%
3 Financials 9.23%
4 Consumer Discretionary 7.66%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRM
6551
DELISTED
Streamline Health Solutions
STRM
-27
Closed
TANH icon
6552
Tantech Holdings
TANH
$6.05M
0
TARA icon
6553
Protara Therapeutics
TARA
$227M
$0 ﹤0.01%
3
-248
-99% -$4.38K
TENX icon
6554
Tenax Therapeutics
TENX
$401M
0
TNXP icon
6555
Tonix Pharmaceuticals
TNXP
$161M
0
TOVX icon
6556
Theriva Biologics
TOVX
$9.64M
$0 ﹤0.01%
1
-1
-50% -$144
TRNS icon
6557
Transcat
TRNS
$778M
$0 ﹤0.01%
29
-1,557
-98% -$38.1K
TROO icon
6558
TROOPS Inc
TROO
$213M
-1,320
Closed -$1K
UAVS icon
6559
AgEagle Aerial Systems
UAVS
$41.9M
0
USIO icon
6560
Usio Inc
USIO
$59.1M
-5
Closed
VRNA
6561
DELISTED
Verona Pharma
VRNA
-1
Closed
VTSI icon
6562
VirTra
VTSI
$35.7M
-13
Closed
VIVO
6563
VivoPower PLC
VIVO
$109M
$0 ﹤0.01%
+10
New +$123
WHLR
6564
Wheeler Real Estate Investment Trust
WHLR
$641K
0
WILC icon
6565
G. Willi-Food International
WILC
$376M
-1
Closed
WORX
6566
DELISTED
SCWORX CORP NEW
WORX
-1
Closed -$1K
XBIT icon
6567
XBiotech
XBIT
$68.3M
$0 ﹤0.01%
38
-8,788
-100% -$76.4K
NTRP icon
6568
NextTrip
NTRP
$24.3M
-2
Closed -$1K
XTIA icon
6569
XTI Aerospace
XTIA
$58.9M
0
AIFC
6570
AI Financial Corp
AIFC
$52.1M
$0 ﹤0.01%
+42
New +$180
XYLO
6571
DELISTED
Xylo Technologies
XYLO
$0 ﹤0.01%
1
-1
-50% -$107
GRDX
6572
GridAI Technologies Corp
GRDX
$21.4M
0
-$3K
ATYR
6573
aTyr Pharma
ATYR
$47.1M
-244
Closed -$2K
QCLS
6574
Q/C Technologies Inc
QCLS
$21.3M
0
HURA
6575
TuHURA Biosciences
HURA
$138M
0

Similar funds

Morgan Stanley's Q2 2019 Portfolio in Review

As of Q2 2019, Morgan Stanley held 6,974 positions worth $376B, up 6.4% from $353B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q2 2019 filing shows 204 new, 3,048 increased, 3,002 reduced and 164 closed positions. Its largest new stake was Uber: 20,700,032 shares worth $960M. The largest sale was Starbucks, an estimated $610M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q2 2019 buy was Uber: 20,700,032 shares worth $960M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $2.28B increase.
  • Morgan Stanley's biggest Q2 2019 reduction was Starbucks, cutting an estimated $610M.
  • Morgan Stanley fully exited Churchill Capital Corp in Q2 2019, selling an estimated $70.9M.
  • Morgan Stanley's ten largest holdings make up 15% of its $376B portfolio in Q2 2019.
  • Morgan Stanley opened 204 new positions and closed 164 in Q2 2019.
  • Morgan Stanley's portfolio value rose 6.4% quarter-over-quarter to $376B.

Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.